Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445

Bats Are Natural Reservoirs of SARS-Like Coronaviruses

Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256

Severe acute respiratory syndrome

Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,157

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955

Human aminopeptidase N is a receptor for human coronavirus 229E

Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., & Holmes, K. V. (1992) · Nature · doi:10.1038/357420a0 · Cited by 941

Endocrine and metabolic aspects of the COVID-19 pandemic

Marazuela, M., Giustina, A., & Puig‐Domingo, M. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09569-2 · Cited by 221

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

Pascal, K. E., Coleman, C. M., Mujica, A. O., Kamat, V., Badithe, A., Fairhurst, J. L., Hunt, C., Strein, J., Berrebi, A. A., Sisk, J. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510830112 · Cited by 217

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., Fernandez-Rodriguez, B., Foglierini, M., Agatic, G., Vanzetta, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510199112 · Cited by 216

Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein

Jiang, L., Wang, N., Zuo, T., Shi, X., Poon, V. K., Wu, Y., Gao, F., Li, D., Wang, R., Guo, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008140 · Cited by 215

Coronaviruses

Maier, H. J., Bickerton, E., & Britton, P. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7 · Cited by 225

COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

Landstra, C. P., & de Koning, E. J. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.649525 · Cited by 226

Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset

Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A. L., Okumura, A., Peng, X., Thomas, M. J., van Doremalen, N., Haddock, E., Nagy, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004250 · Cited by 209

Severe acute respiratory syndrome vs. the Middle East respiratory syndrome

Hui, D. S. C., Memish, Z. A., & Zumla, A. I. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000046 · Cited by 211

Coronaviruses: An Updated Overview of Their Replication and Pathogenesis

Wang, Y., Grunewald, M. E., & Perlman, S. M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0900-2_1 · Cited by 216

The Immune Response and Immunopathology of COVID-19

Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 210

Evidence for SARS-CoV-2 Infection of Animal Hosts

Abdel-Moneim, A. S., & Abdelwhab, E. M. (2020) · Pathogens · doi:10.3390/pathogens9070529 · Cited by 209

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies

Dyall, J., Gross, R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Hensley, L. E., Frieman, M. B., & Jahrling, P. B. (2017) · Drugs · doi:10.1007/s40265-017-0830-1 · Cited by 203

Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes

Wang, A., Chiou, J., Poirion, O., Buchanan, J., Valdez, M. J., Verheyden, J. M., Hou, X., Kudtarkar, P., Narendra, S., Newsome, J. M., et al. (2020) · eLife · doi:10.7554/elife.62522 · Cited by 207

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways

Mazewski, C., Perez, R. E., Fish, E. N., & Platanias, L. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606456 · Cited by 209

Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies

Li, C., Li, W., de Esesarte, E. L., Guo, H., van den Elzen, P., Aarts, E., van den Born, E., Rottier, P. J. M., & Bosch, B. (2017) · Journal of Virology · doi:10.1128/jvi.00273-17 · Cited by 203

Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, ChinaPreprint

Cao, M., Zhang, D., Wang, Y., Lu, Y., Zhu, X., Li, Y., Xue, H., Lin, Y.-X., Zhang, M., Sun, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20030395 · Cited by 199

Isolation of MERS Coronavirus from a Dromedary Camel, Qatar, 2014

Raj, V. S., Farag, E., Reusken, C. B. E. M., Lamers, M. M., Pas, S. D., Voermans, J. J. C., Smits, S. L., Osterhaus, A. D. M. E., Al-Mawlawi, N., Al‐Romaihi, H. E., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2008.140663 · Cited by 197

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

Solerte, S. B., Sabatino, A. D., Galli, M., & Fiorina, P. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01539-z · Cited by 197

The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis

Waumans, Y., Baerts, L., Kehoe, K., Lambeir, A., & Meester, I. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00387 · Cited by 194

Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist

Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G. L., Suliman, T., Barchet, W., Weber, F., Drosten, C., & Müller, M. A. (2013) · Journal of Virology · doi:10.1128/jvi.01845-13 · Cited by 190

DPP4 in Cardiometabolic Disease

Zhong, J., Maiseyeu, A., Davis, S. N., & Rajagopalan, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.305665 · Cited by 190

Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea

Bin, S. Y., Heo, J. Y., Song, M., Lee, J., Kim, E.-H., Park, S., Kwon, H.-I., Kim, S., Kim, Y., Si, Y., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1020 · Cited by 188

Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells

Chu, H., Chan, C.-M., Zhang, X., Wang, Y., Yuan, S., Zhou, J., Au-Yeung, R. K. H., Sze, K. H., Yang, D., Shuai, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001897 · Cited by 188

Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction

Omrani, A. S., Al‐Tawfiq, J. A., & Memish, Z. A. (2015) · Pathogens and Global Health · doi:10.1080/20477724.2015.1122852 · Cited by 185

Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease

Vijayakumar, B., Boustani, K., Ogger, P. P., Papadaki, A., Tonkin, J., Orton, C. M., Ghai, P., Suveizdytė, K., Hewitt, R. J., Desai, S. R., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.017 · Cited by 188

Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19

Bernard, I., Limonta, D., Mahal, L. K., & Hobman, T. C. (2020) · Viruses · doi:10.3390/v13010029 · Cited by 187

Respiratory Tract Samples, Viral Load, and Genome Fraction Yield in Patients With Middle East Respiratory Syndrome

Memish, Z. A., Al‐Tawfiq, J. A., Makhdoom, H. Q., Assiri, A. M., Alhakeem, R. F., Albarrak, A. M., Alsubaie, S., Al-Rabeeah, A. A., Hajomar, W. H., Hussain, R., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu292 · Cited by 181

Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract

Meyerholz, D. K., Lambertz, A. M., & McCray, P. B. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.014 · Cited by 181

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice

Li, K., Wohlford-Lenane, C., Channappanavar, R., Park, J.-E., Earnest, J. T., Bair, T., Bates, A. M., Brogden, K. A., Flaherty, H. A., Gallagher, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619109114 · Cited by 184

Animal models for SARS and MERS coronaviruses

Gretebeck, L., & Subbarao, K. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.06.009 · Cited by 185

Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms

Adedeji, A. O., Severson, W. E., Jonsson, C. B., Singh, K., Weiss, S. R., & Sarafianos, S. G. (2013) · Journal of Virology · doi:10.1128/jvi.00998-13 · Cited by 180

Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)

Munster, V. J., Adney, D. R., van Doremalen, N., Brown, V. R., Miazgowicz, K. L., Milne-Price, S., Bushmaker, T., Rosenke, R., Scott, D. P., Hawkinson, A., et al. (2016) · Scientific Reports · doi:10.1038/srep21878 · Cited by 180

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature

Katulanda, P., Dissanayake, H. A., Ranathunga, I., Ratnasamy, V., Wijewickrama, P. S. A., Yogendranathan, N., Gamage, K. K. K., de Silva, N. L., Sumanatilleke, M., Somasundaram, N. P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05164-x · Cited by 186

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response

Chu, H., Zhou, J., Wong, B. H., Li, C., Cheng, Z., Lin, X., Poon, V. K., Sun, T., Lau, C. C.-Y., Chan, J. F., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 180

Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2

Körner, R. W., Majjouti, M., Alcazar, M. A. A., & Mahabir, E. (2020) · Viruses · doi:10.3390/v12080880 · Cited by 184

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19

Johnson, K. D., Harris, C. C., Cain, J., Hummer, C., Goyal, H., & Perisetti, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00526 · Cited by 185

Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects

Zumla, A. I., Al‐Tawfiq, J. A., Enne, V. I., Kidd, M., Drosten, C., Breuer, J., Müller, M. A., Hui, D. S. C., Maeurer, M. J., Bates, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70827-8 · Cited by 175

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

Du, L., Zhao, G., Kou, Z., Ma, C., Sun, S., Poon, V. K., Lu, L., Wang, L., Debnath, A. K., Zheng, B.-J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01048-13 · Cited by 177

Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus

Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y. L., Geng, H., Li, H., Wang, Q., Xiao, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02433-13 · Cited by 175

Structural basis for broad coronavirus neutralization

Sauer, M. M., Tortorici, M. A., Park, Y., Walls, A. C., Homad, L. J., Acton, O. J., Bowen, J. E., Wang, C., Xiong, X., de van der Schueren, W., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00596-4 · Cited by 175

Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus

Raj, V. S., Smits, S. L., Provacia, L. B., van den Brand, J. M. A., Wiersma, L., Ouwendijk, W. J. D., Bestebroer, T. M., Spronken, M. I. J., van Amerongen, G., Rottier, P. J. M., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02935-13 · Cited by 172

Modeling the viral dynamics of SARS-CoV-2 infection

Wang, S., Pan, Y., Wang, Q., Miao, H., Brown, A. N., & Rong, L. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108438 · Cited by 173

Viral Emerging Diseases: Challenges in Developing Vaccination Strategies

Trovato, M., Sartorius, R., D’Apice, L., Manco, R., & Berardinis, P. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02130 · Cited by 177

History of the COVID-19 pandemic: Origin, explosion, worldwide spreading

Platto, S., Wang, Y., Zhou, J., & Carafoli, E. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.087 · Cited by 180

Viral infection in community-acquired pneumonia: a systematic review and meta-analysis

Burk, M., El‐Kersh, K., Saad, M., Wiemken, T. L., Ramírez, J. A., & Cavallazzi, R. (2016) · European Respiratory Review · doi:10.1183/16000617.0076-2015 · Cited by 168

Viral and host heterogeneity and their effects on the viral life cycle

Jones, J. E., Sage, V. L., & Lakdawala, S. S. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00449-9 · Cited by 173

Factors leading to high morbidity and mortality of COVID ‐19 in patients with type 2 diabetes

Rajpal, A., Rahimi, L., & Ismail‐Beigi, F. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13085 · Cited by 178

Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis

Liu, Q., & Wang, H.-Y. (2021) · Veterinary Research Communications · doi:10.1007/s11259-021-09808-0 · Cited by 169

Identification of New Respiratory Viruses in the New Millennium

Berry, M. J., Gamieldien, J., & Fielding, B. C. (2015) · Viruses · doi:10.3390/v7030996 · Cited by 163

Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation

McCallum, M., Walls, A. C., Bowen, J. E., Corti, D., & Veesler, D. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0483-8 · Cited by 166

Current advancements and potential strategies in the development of MERS-CoV vaccines

Zhang, N., Jiang, S., & Du, L. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.912134 · Cited by 160

Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein

Kleine‐Weber, H., Elzayat, M. T., Hoffmann, M., & Pöhlmann, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-34859-w · Cited by 164

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know

Sun, C., Wang, Y.-Y., Liu, G.-H., & Liu, Z. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00155 · Cited by 162

COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches

Moccia, F. D., Gerbino, A., Lionetti, V., Miragoli, M., Munaron, L., Pagliaro, P., Pasqua, T., Penna, C. R. R., Rocca, C., Samaja, M., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00198-w · Cited by 165

Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives

Roychoudhury, S., Das, A., Sengupta, P., Dutta, S., Roychoudhury, S., Roychoudhury, S., Ahmed, A. B. F., Bhattacharjee, S., & Sláma, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249411 · Cited by 167

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

Low, J. S., Jerak, J., Tortorici, M. A., McCallum, M., Pinto, D., Cassotta, A., Foglierini, M., Mele, F., Abdelnabi, R., Weynand, B., et al. (2022) · Science · doi:10.1126/science.abq2679 · Cited by 163

The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19

Ye, Q., Wang, B., Zhang, T., Xu, J., & Shang, S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00148.2020 · Cited by 162

Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection

Edwards, C. E., Yount, B. L., Graham, R. L., Leist, S. R., Hou, Y. J., Dinnon, K. H., Sims, A. M., Swanstrom, J., Gully, K. L., Scobey, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001046117 · Cited by 162

COVID-19: Complement, Coagulation, and Collateral Damage

Lo, M. W., Kemper, C., & Woodruff, T. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000644 · Cited by 160

A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines

Du, L., Kou, Z., Ma, C., Tao, X., Wang, L., Zhao, G., Chen, Y.-Q., Yu, F., Tseng, C.-T. K., Zhou, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081587 · Cited by 161

Ferret models of viral pathogenesis

Enkirch, T., & von Messling, V. (2015) · Virology · doi:10.1016/j.virol.2015.03.017 · Cited by 158

Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins

Shang, J., Zheng, Y., Yang, Y., Liu, C., Geng, Q., Luo, C., Zhang, W., & Li, F. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007009 · Cited by 158

Epidemic and pandemic viral infections: impact on tuberculosis and the lung

Ong, C. W. M., Migliori, G. B., Raviglione, M. C., Macgregor-Skinner, G., Sotgiu, G., Alffenaar, J. C., Tiberi, S., Adlhoch, C., Alonzi, T., Archuleta, S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01727-2020 · Cited by 163

Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)

Hui, D. S. C. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.11.007 · Cited by 159

Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies

Market, M., Angka, L., Martel, A. B., Bastin, D. J., Olanubi, O., Tennakoon, G., Boucher, D. M., Ng, J., Ardolino, M., & Auer, R. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01512 · Cited by 158

Close relatives of MERS-CoV in bats use ACE2 as their functional receptors

Xiong, Q., Cao, L., Ma, C., Tortorici, M. A., Liu, C., Si, J., Liu, P., Gu, M., Walls, A. C., Wang, C., et al. (2022) · Nature · doi:10.1038/s41586-022-05513-3 · Cited by 160

Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy

Momattin, H., Mohammed, K., Zumla, A. I., Memish, Z. A., & Al‐Tawfiq, J. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.07.002 · Cited by 152

Link of a ubiquitous human coronavirus to dromedary camels

Corman, V. M., Eckerle, I., Memish, Z. A., Liljander, A., Dijkman, R., Jónsdóttir, H. R., Ngeiywa, K. J. Z. J., Kamau, E., Younan, M., Masri, M. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604472113 · Cited by 152

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

Volz, A., Kupke, A., Song, F., Jany, S., Fux, R., Shams-Eldin, H., Schmidt, J., Becker, C., Eickmann, M., Becker, S., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00614-15 · Cited by 151

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection

Padmanabhan, P., Desikan, R., & Dixit, N. M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008461 · Cited by 152

Pathogenesis of Middle East respiratory syndrome coronavirus

van den Brand, J. M. A., Smits, S. L., & Haagmans, B. L. (2014) · The Journal of Pathology · doi:10.1002/path.4458 · Cited by 154

Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus

Lundin, A., Dijkman, R., Bergström, T. B., Kann, N. C., Adamiak, B., Hannoun, C., Kindler, E., Jónsdóttir, H. R., Muth, D., Kint, J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004166 · Cited by 150

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein

Li, Y., Wan, Y., Liu, P., Zhao, J., Lu, G., Qi, J., Wang, Q., Lu, X., Wu, Y., Liu, W., et al. (2015) · Cell Research · doi:10.1038/cr.2015.113 · Cited by 150

Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle East Respiratory Syndrome Coronavirus

Luo, C.-M., Wang, N., Yang, X., Liu, H.-Z., Zhang, W., Li, B., Hu, B., Peng, C., Geng, Q.-B., Zhu, G.-J., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00116-18 · Cited by 154

Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2

Yu, S., Zhu, Y., Xu, J., Yao, G., Zhang, P., Wang, M., Zhao, Y., Lin, G., Chen, H., Chen, L., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153364 · Cited by 152

Characterization of a Novel Betacoronavirus Related to Middle East Respiratory Syndrome Coronavirus in European Hedgehogs

Corman, V. M., Kallies, R., Philipps, H., Göpner, G., Müller, M. A., Eckerle, I., Brünink, S., Drosten, C., & Drexler, J. F. (2013) · Journal of Virology · doi:10.1128/jvi.01600-13 · Cited by 149

Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin

Millet, J. K., Séron, K., Labitt, R. N., Danneels, A., Palmer, K. E., Whittaker, G. R., Dubuisson, J., & Belouzard, S. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.07.011 · Cited by 148

AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?

Reperant, L. A., & Osterhaus, A. D. M. E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.082 · Cited by 151

COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 ( DPP4 ) in disease severity?

Bassendine, M. F., Bridge, S. H., McCaughan, G. W., & Gorrell, M. D. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13052 · Cited by 149

The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases

Earnest, J. T., Hantak, M. P., Li, K., McCray, P. B., Perlman, S. M., & Gallagher, T. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006546 · Cited by 150

Targeting the Adipose Tissue in COVID‐19

Malavazos, A. E., Romanelli, M. M. C., Bandera, F., & Iacobellis, G. (2020) · Obesity · doi:10.1002/oby.22844 · Cited by 153

Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients

Itani, R., Tobaiqy, M. A., & Faraj, A. A. (2020) · Theranostics · doi:10.7150/thno.46691 · Cited by 146

Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies

Song, F., Fux, R., Provacia, L. B., Volz, A., Eickmann, M., Becker, S., Osterhaus, A. D. M. E., Haagmans, B. L., & Sutter, G. (2013) · Journal of Virology · doi:10.1128/jvi.01672-13 · Cited by 145

Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin

Lokugamage, K. G., Narayanan, K., Nakagawa, K., Terasaki, K., Ramirez, S. I., Tseng, C.-T. K., & Makino, S. (2015) · Journal of Virology · doi:10.1128/jvi.01352-15 · Cited by 145

Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development

Samrat, S. K., Tharappel, A. M., Li, Z., & Li, H. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198141 · Cited by 148

The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”

Chan, J. F., Lau, S. K. P., & Woo, P. C. Y. (2013) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2013.05.010 · Cited by 144

Diabetes and COVID-19

Peric, S., & Stulnig, T. M. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01672-3 · Cited by 148

Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization

Kleine‐Weber, H., Elzayat, M. T., Wang, L., Graham, B. S., Müller, M. A., Drosten, C., Pöhlmann, S., & Hoffmann, M. (2018) · Journal of Virology · doi:10.1128/jvi.01381-18 · Cited by 143

IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms

Wrensch, F., Winkler, M., & Pöhlmann, S. (2014) · Viruses · doi:10.3390/v6093683 · Cited by 142

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2

Mou, H., Quinlan, B. D., Peng, H., Liu, G., Guo, Y., Peng, S., Zhang, L., Davis-Gardner, M. E., Gardner, M. R., Crynen, G. C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009501 · Cited by 147

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

Zhao, G., Du, L., Ma, C., Li, Y., Li, L., Poon, V. K., Wang, L., Yu, F., Zheng, B.-J., Jiang, S., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-266 · Cited by 144

Role of Hypertension on the Severity of COVID-19: A Review

Peng, M., He, J., Xue, Y., Xue, Y., Liu, S., & Gong, Z. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001116 · Cited by 147

Porcine Deltacoronavirus Engages the Transmissible Gastroenteritis Virus Functional Receptor Porcine Aminopeptidase N for Infectious Cellular Entry

Wang, B., Liu, Y., Ji, C., Yang, Y., Liang, Q., Zhao, P., Xu, L.-D., Lei, X., Luo, W.-T., Qin, P., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00318-18 · Cited by 141

The Potential Intermediate Hosts for SARS-CoV-2

Zhao, J., Cui, W., & Tian, B. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.580137 · Cited by 148

Virus-Mediated Cell-Cell Fusion

Leroy, H., Han, M., Woottum, M., Bracq, L., Bouchet, J., Xie, M., & Bénichou, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249644 · Cited by 149

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs

Rebendenne, A., Roy, P., Bonaventure, B., Valadão, A. L. C., Desmarets, L. M. B., Arnaud‐Arnould, M., Rouillé, Y., Tauziet, M., Giovannini, D., Touhami, J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01110-2 · Cited by 147

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters

de Wit, E., Prescott, J. B., Baseler, L. J., Bushmaker, T., Thomas, T., Lackemeyer, M. G., Martellaro, C., Milne-Price, S., Haddock, E., Haagmans, B. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069127 · Cited by 139

Cryo-Electron Microscopy Structure of Porcine Deltacoronavirus Spike Protein in the Prefusion State

Shang, J., Zheng, Y., Yang, Y., Liu, C., Geng, Q., Tai, W., Du, L., Zhou, Y., Zhang, W., & Li, F. (2017) · Journal of Virology · doi:10.1128/jvi.01556-17 · Cited by 141

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines

Ma, C., Li, Y., Wang, L., Zhao, G., Tao, X., Tseng, C.-T. K., Zhou, Y., Du, L., & Jiang, S. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.004 · Cited by 139

A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein

Du, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., Tao, X., Yu, H., Sun, S., Tseng, C.-T. K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00433-14 · Cited by 142

Broad reception for coronavirus

Gallagher, T., & Perlman, S. M. (2013) · Nature · doi:10.1038/495176a · Cited by 32

Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus

Perlman, S. M., & Zhao, J. (2013) · mBio · doi:10.1128/mbio.00002-13 · Cited by 22

Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines

Müller, M. A., Raj, V. S., Muth, D., Meyer, B., Kallies, S., Smits, S. L., Wollny, R., Bestebroer, T. M., Specht, S., Suliman, T., et al. (2012) · mBio · doi:10.1128/mbio.00515-12 · Cited by 209

Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4

Jiang, S., Lu, L., Du, L., & Debnath, A. K. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.04.007 · Cited by 12

The Emergence of Human Coronavirus EMC: How Scared Should We Be?

Chan, R. W. Y., & Poon, L. L. M. (2013) · mBio · doi:10.1128/mbio.00191-13 · Cited by 11